The "Health Industry Park" of Chengyi Pharmaceutical was completed in September 2019 and was basically put into operation in March 2020. The picture shows an overview of the "Health Industrial Park"
Cheng Yi Pharmaceuticalfounded in 1966, has actively leveraged the advantages of Dongtou as a Marine Economy Development Demonstration Zone to advance marine biopharmaceuticals. It has transformed from a small workshop-style pharmaceutical factory run by military dependents into Wenzhou's first listed pharmaceutical enterprise and Zhejiang's first listed company in the marine biopharmaceutical sector.Integrating R&D, production and sales, the company currently produces over 90 types of pharmaceuticals and health food products. During the "14th Five-Year Plan" period, it will focus on developing the "Two Strengths and One Scale" project – Asia’s largest production base with an annual output of 2,000 tons of glucosamine API and 1,000 tons of super fish oil. It will accelerate the transformation and upgrading from "generic drugs" to "innovative drugs", strive to become a "leading enterprise" and "top-tier enterprise" in Zhejiang's marine biopharmaceutical industry, and make great efforts to write a "Cheng Yi chapter" for Chinese-style modernization.
The company took the lead in pursuing international certifications in 1998, with multiple products having obtained approvals from authorities including the U.S. FDA, EU EMEA, Australia TGA, UK MHRA, and Mexico COFEPRIS.Since June 2018, it has established a Shanghai Marketing Center, 14 regional offices, and 3 provincial sales departments across the country. Its product distribution network covers the entire domestic market, while its international market reach extends to over 20 countries and regions in Europe, America, India, South Africa, and Southeast Asia.
Comrade Fu Bangwu, the workshop director of the company, was awarded the 2022 National May Day Labor Medal
General Manager Zhao Chunjian accompanied Dongtou District Party Secretary Guo Yunqiang to visit the provincial digital workshop for small capacity injections
Provincial and municipal leaders such as Zhang Dejiang, Li Zemin, Chai Songyue, Yuan Jiajun, Wang Hao, Chen Yijun, Zhao Yide, Liu Xiaotao, Chen Weijun, Yao Gaoguan, and Zhang Zhenfeng also successively inspected Chengyi Pharmaceutical.
The future of Chengyi Pharmaceutical will revolve around the three major development directions of "marine medicine, biopharmaceutical, and traditional Chinese medicine" and the dual goals of "10 billion market value, 100 years of sincerity", accelerate mergers and acquisitions, seize strategic heights, empower enterprises with new value, and achieve company collectivization and high-quality development.